Singapore markets open in 4 hours 8 minutes

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.93-0.10 (-1.00%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.03
Open10.02
Bid9.89 x 400
Ask9.98 x 400
Day's range9.83 - 10.27
52-week range3.81 - 17.70
Volume263,068
Avg. volume297,147
Market cap586.53M
Beta (5Y monthly)0.25
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference

    MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, at 2:35 p.m. EDT. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.

  • GlobeNewswire

    IGM Biosciences Announces Refocusing of Sanofi Collaboration

    Agreement focuses on immunology/inflammation, aligning with Sanofi’s ongoing commitment to advancing therapies for patients across multiple inflammatory diseasesMOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that the Company’s exclusive worldwide collaboration agreement with Sanofi to create and develop IgM agonist antibodies will now focus ex

  • GlobeNewswire

    IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

    MOUNTAIN VIEW, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Stifel 2024 Virtual Targeted Oncology Forum on Wednesday, April 17, 2024, at 12:00 p.m. EDT. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of t